Kirstin Zettlitz
Target Biology Lead Stealth Radiopharma
Kirstin Zettlitz, PhD, is the Target Biology Lead at Stealth Radiopharma, specializing in the preclinical development and clinical translation of radiopharmaceutical therapies.
She earned her PhD from the University of Stuttgart, Germany, conducted her postdoctoral training at UCLA, and is a former Assistant Professor at City of Hope were her research focused on antibody engineering for immunoTheranostics (optical, immunoPET and radioimmunotherapy) for prostate and pancreatic cancers.
Seminars
Tuesday 21st July 2026
Harnessing the Power of Antibodies, Peptides, & Small Molecules to Optimize RLT Performance
11:00 am
- Comparing antibodies, antibody fragments, peptides, and small molecules for different RLT applications
- Evaluating how moiety choice influences tumor uptake, internalization, and off-target exposure
- Applying practical lessons to match targeting format with clinical objectives and therapeutic strategy
